052907410	052907410	CD	B-NP	O
|	|	NNP	I-NP	O
SKHS	SKHS	NNP	I-NP	O
|	|	VBD	B-VP	O
50999409	50999409	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
221016	221016	CD	B-NP	O
|	|	CC	I-NP	O
10/22/2002	10/22/2002	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CHF	CHF	NN	I-NP	I-protein
exacerbation	exacerbation	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/21/2002	1/21/2002	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/24/2002	10/24/2002	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
GERICH	GERICH	NNP	B-NP	O
,	,	,	O	O
ANDREAS	ANDREAS	NNP	B-NP	O
A	A	NNP	I-NP	O
935-72-18-7	935-72-18-7	CD	I-NP	O
As	As	IN	B-PP	O
Service	Service	NNP	B-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
9/5/02	9/5/02	CD	B-NP	O
AT	AT	NN	I-NP	O
03	03	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
Attending	Attend	VBG	B-VP	O
evaluation	evaluation	NN	B-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
LEISCHNER	LEISCHNER	NN	B-NP	O
,	,	,	O	O
KENNY	KENNY	NNP	B-NP	O
BRICE	BRICE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
TYLENOL	TYLENOL	NN	B-NP	B-protein
#	#	#	B-NP	I-protein
3	3	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	O
ACETAMINOPHEN	ACETAMINOPHEN	NN	I-NP	O
W/CODEINE	W/CODEINE	NN	I-NP	O
30MG	30MG	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
1-2	1-2	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
Q4-6H	Q4-6H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
pain	pain	NN	I-NP	O
ATENOLOL	ATENOLOL	NN	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
PREMARIN	PREMARIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
CONJUGATED	CONJUGATED	NNP	I-NP	O
ESTROGENS	ESTROGENS	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1.25	1.25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
PROZAC	PROZAC	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
FLUOXETINE	FLUOXETINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QID	QID	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
2/17/02	2/17/02	CD	B-NP	O
by	by	IN	B-PP	O
WHITTIER	WHITTIER	NNP	B-NP	O
,	,	,	O	O
LORENZO	LORENZO	NNP	B-NP	O
G	G	NNP	I-NP	O
D.	D.	NNP	I-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
HCTZ	HCTZ	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
96303640	96303640	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
FLUOXETINE	FLUOXETINE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Aware	Aware	NN	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/17/02	2/17/02	CD	B-NP	O
by	by	IN	B-PP	O
SIEMINSKI	SIEMINSKI	NNP	B-NP	O
,	,	,	O	O
WILLIS	WILLIS	NNP	B-NP	O
G.	G.	NNP	I-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LASIX	LASIX	NN	B-NP	B-protein
IV	IV	CD	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
03201159	03201159	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
FLUOXETINE	FLUOXETINE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
,	,	,	O	O
INJ	INJ	NNP	B-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Aware	Aware	NN	B-NP	O
HCTZ	HCTZ	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
12.5	12.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/17/02	2/17/02	CD	B-NP	O
by	by	IN	B-PP	O
PENEZ	PENEZ	NNP	B-NP	B-protein
,	,	,	O	O
DOMENIC	DOMENIC	NNP	B-NP	O
B.	B.	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
FLUOXETINE	FLUOXETINE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Aware	Aware	NNP	B-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
12/10/02	12/10/02	CD	B-NP	O
by	by	IN	B-PP	O
THESING	THESING	NNP	B-NP	O
,	,	,	O	O
LLOYD	LLOYD	NNP	B-NP	O
W.	W.	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Aware	Aware	NN	B-NP	O
AMLODIPINE	AMLODIPINE	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

NEURONTIN	NEURONTIN	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
GABAPENTIN	GABAPENTIN	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
800	800	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QID	QID	NNP	I-NP	I-protein
DETROL	DETROL	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
TOLTERODINE	TOLTERODINE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
2	2	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
3	3	CD	B-NP	O
CELEBREX	CELEBREX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CELECOXIB	CELECOXIB	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
200	200	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
with	with	IN	B-PP	O
food	food	NN	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
12/10/02	12/10/02	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
DEFINITE	DEFINITE	NN	B-NP	O
ALLERGY	ALLERGY	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
NSAID	NSAID	NNP	B-NP	O
'S	'S	NNP	I-NP	O
POSSIBLE	POSSIBLE	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
NSAID	NSAID	NNP	B-NP	O
'S	'S	NNP	I-NP	O
DEFINITE	DEFINITE	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
NSAID	NSAID	NNP	B-NP	O
'S	'S	POS	B-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
Takes	Take	VBZ	B-VP	O
regularly	regularly	RB	B-ADVP	O
LASIX	LASIX	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
;	;	:	O	O
20	20	CD	B-NP	O
MG	MG	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
July	July	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
12/10/02	12/10/02	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NN	B-NP	O
SERIOUS	SERIOUS	NN	I-NP	O
INTERACTION	INTERACTION	NN	I-NP	O
:	:	:	O	O
FLUOXETINE	FLUOXETINE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
takes	take	VBZ	B-VP	O
regulary	regulary	NN	B-NP	O
;	;	:	O	O
Aware	Aware	NN	B-NP	O
ALBUTEROL	ALBUTEROL	NN	I-NP	O
NEBULIZER	NEBULIZER	NN	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NN	I-NP	O
NEB	NEB	NN	I-NP	O
Q4H	Q4H	NN	I-NP	O
ALBUTEROL	ALBUTEROL	NN	I-NP	O
INHALER	INHALER	NN	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NN	I-NP	O
QID	QID	NN	I-NP	O
ATROVENT	ATROVENT	NN	I-NP	O
NEBULIZER	NEBULIZER	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
IPRATROPIUM	IPRATROPIUM	NN	I-NP	O
NEBULIZER	NEBULIZER	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
0.5	0.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
NEB	NEB	NNP	I-NP	O
QID	QID	NNP	I-NP	O
ATROVENT	ATROVENT	NNP	I-NP	O
INHALER	INHALER	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
IPRATROPIUM	IPRATROPIUM	NNP	I-NP	O
INHALER	INHALER	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NN	I-NP	O
QID	QID	NN	I-NP	O
OSCAL	OSCAL	NN	I-NP	O
500	500	CD	I-NP	O
+	+	SYM	I-NP	O
D	D	NN	I-NP	O
-LRB-	-LRB-	SYM	B-NP	O
CALCIUM	CALCIUM	NN	I-NP	B-protein
CARB	CARB	NN	I-NP	I-protein
+	+	SYM	B-NP	O
D	D	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
500MG	500MG	NNP	I-NP	O
ELEM	ELEM	NNP	I-NP	O
C.	C.	NNP	I-NP	O
.	.	.	O	O
.	.	''	O	O
-RRB-	-RRB-	.	O	B-protein

1	1	CD	B-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
QID	QID	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
Restrictions	Restriction	NNS	I-NP	O
RETURN	RETURN	NNP	B-NP	O
TO	TO	NNP	I-NP	O
WORK	WORK	NNP	I-NP	O
:	:	:	O	O
Not	Not	NNP	B-NP	O
Applicable	Applicable	NNP	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Colar	Colar	NNP	I-NP	O
9/21/02	9/21/02	CD	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
,	,	,	O	O
Iron	Iron	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ferrous	ferrous	JJ	I-NP	O
sulfate	sulfate	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
Nsaid	Nsaid	NNP	B-NP	O
's	's	POS	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CHF	CHF	NNP	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
obesity	obesity	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
obesity	obesity	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
restrictive	restrictive	JJ	I-NP	O
lung	lung	NN	I-NP	O
disease	disease	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
restrictive	restrictive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
chf	chf	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
fibromyalgia	fibromyalgia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
fibromyalgia	fibromyalgia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
von	von	NN	I-NP	O
willebrand	willebrand	NN	I-NP	O
's	's	POS	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
hemophilia	hemophilia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
iron	iron	NN	I-NP	O
deficiency	deficiency	NN	I-NP	O
anemia	anemia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
iron	iron	NN	I-NP	O
deficiency	deficiency	NN	I-NP	O
anemia	anemia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hypoxia	hypoxia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypoxia	hypoxia	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
GERD	GERD	NNP	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
TAH/BSO	TAH/BSO	NN	I-NP	O
,	,	,	O	O
PICA	PICA	NN	B-NP	B-protein
.	.	.	O	O
?	?	.	O	O

central	central	JJ	B-NP	O
hypoventilation	hypoventilation	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
.	.	.	O	O

OA	OA	NN	B-NP	O
.	.	.	O	O

OPERATIONS	OPERATIONS	NNS	B-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NNP	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
None	None	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
44	44	CD	B-NP	O
yo	yo	NN	I-NP	O
f	f	NN	I-NP	O
with	with	IN	B-PP	O
complex	complex	JJ	B-NP	O
medical	medical	JJ	I-NP	O
hx	hx	NN	I-NP	O
including	include	VBG	B-PP	O
CHF	CHF	NN	B-NP	B-protein
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
diastolic	diastolic	JJ	B-NP	O
dysfucnction	dysfucnction	NN	I-NP	O
and	and	CC	O	O
Obstructive	Obstructive	JJ	B-NP	O
sleep	sleep	JJ	I-NP	O
apnea/RLD	apnea/RLD	NN	I-NP	O
of	of	IN	B-PP	O
obesity	obesity	NN	B-NP	O
and	and	CC	O	O
von	von	NNP	B-NP	O
Willibrand	Willibrand	NNP	I-NP	O
's	's	POS	B-NP	O
Disease	Disease	NN	I-NP	O
presented	present	VBN	B-VP	O
to	to	TO	B-PP	O
Skywoodl	Skywoodl	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
with	with	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
SOB	SOB	NN	B-NP	B-protein
and	and	CC	O	O
pedal	pedal	JJ	B-NP	O
edema	edema	NN	I-NP	O
and	and	CC	O	O
increased	increase	VBD	B-VP	O
O2	O2	NN	B-NP	O
requirement	requirement	NN	I-NP	O
to	to	TO	B-PP	O
8L	8L	NN	B-NP	O
last	last	JJ	B-NP	O
night	night	NN	I-NP	O
from	from	IN	B-PP	O
baseline	baseline	NN	B-NP	O
4L	4L	NN	I-NP	O
requirement	requirement	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
F/C/N	F/C/N	NN	B-NP	B-protein
/	/	SYM	I-NP	O
V	V	NN	I-NP	O
but	but	CC	O	O
reports	report	NNS	B-NP	O
increased	increase	VBD	B-VP	O
yellow	yellow	JJ	B-NP	O
sputum	sputum	NN	I-NP	O
production	production	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
1-2	1-2	CD	I-NP	O
mo.	mo.	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
dietary	dietary	JJ	I-NP	O
indescretion	indescretion	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
noncompliance	noncompliance	NN	B-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
but	but	CC	O	O
reports	report	NNS	B-NP	O
taking	take	VBG	B-VP	O
them	them	PRP	B-NP	O
faithfully	faithfully	RB	B-ADVP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
month	month	NN	I-NP	O
--	--	:	O	O
she	she	PRP	B-NP	O
brought	bring	VBD	B-VP	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
-LRB-	-LRB-	VBP	B-VP	O
several	several	JJ	B-NP	O
bottles	bottle	NNS	I-NP	O
empty	empty	JJ	B-ADJP	O
,	,	,	O	O
several	several	JJ	B-NP	O
unopened	unopened	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
reports	report	VBZ	B-VP	O
palpitations	palpitation	NNS	B-NP	O
but	but	CC	I-NP	O
reports	report	NNS	I-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
this	this	DT	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
lon	lon	NN	I-NP	O
time	time	NN	I-NP	O
and	and	CC	O	O
associates	associate	VBZ	B-VP	O
it	it	PRP	B-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
anemia	anemia	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
reports	report	VBZ	B-VP	O
CP	CP	NN	B-NP	B-DNA
traveling	travel	VBG	B-VP	O
under	under	IN	B-PP	O
L.	L.	NNP	B-NP	O
breast	breast	NN	I-NP	O
with	with	IN	B-PP	O
coughing	coughing	NN	B-NP	O
,	,	,	O	O
deep	deep	JJ	B-NP	O
inspiration	inspiration	NN	I-NP	O
.	.	.	O	O

PMH	PMH	NN	B-NP	O
:	:	:	O	O
-LRB-	-LRB-	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Obesity	Obesity	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
2	2	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Obstructive	Obstructive	NNP	I-NP	I-protein
Sleep	Sleep	NNP	I-NP	I-protein
Apena	Apena	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
3	3	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Central	Central	NNP	I-NP	I-protein
Hypoventilation	Hypoventilation	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
4	4	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	O
Restrictive	Restrictive	JJ	I-NP	O
lung	lung	NN	I-NP	O
dz	dz	NN	I-NP	O
.	.	.	O	O

secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
obesity	obesity	NN	B-NP	O
,	,	,	O	O
OSA	OSA	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	O
5	5	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
Fybromylgia	Fybromylgia	NN	I-NP	O
/	/	SYM	B-NP	O
pain	pain	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
6	6	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
von	von	NNP	I-NP	O
Willibrand	Willibrand	NNP	I-NP	O
dz	dz	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
7	7	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Stress	Stress	NNP	I-NP	O
Incontinence	Incontinence	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
8	8	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
GERD	GERD	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
9	9	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PICA	PICA	NNP	I-NP	O
A	A	NNP	I-NP	O
&	&	CC	I-NP	O
P	P	NNP	I-NP	O
:	:	:	O	O
44	44	CD	B-NP	O
yo	yo	NN	I-NP	O
f	f	NN	I-NP	O
w/MMP	w/MMP	NN	I-NP	O
and	and	CC	O	O
multiple	multiple	JJ	B-NP	O
admissions	admission	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
for	for	IN	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
likely	likely	JJ	B-NP	O
CHF	CHF	NN	I-NP	O
flare	flare	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
medical	medical	JJ	B-NP	B-protein
noncompliance	noncompliance	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

CV-CHF-JVP	CV-CHF-JVP	NN	B-NP	O
9-10	9-10	CD	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
with	with	IN	B-PP	O
CXR	CXR	NN	B-NP	B-protein
demonstrating	demonstrate	VBG	B-VP	O
vascular	vascular	JJ	B-NP	O
congestion	congestion	NN	I-NP	O
,	,	,	O	O
8L	8L	NN	B-NP	O
O2	O2	NN	I-NP	O
requirement	requirement	NN	I-NP	O
;	;	:	O	O
Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
aggressively	aggressively	RB	I-VP	O
diuresed	diurese	VBN	I-VP	O
with	with	IN	B-PP	O
Lasix	Lasix	NN	B-NP	O
with	with	IN	B-PP	O
O2	O2	NN	B-NP	O
requirement	requirement	NN	I-NP	O
returning	return	VBG	B-VP	O
to	to	TO	B-PP	O
4L	4L	NN	B-NP	O
baseline	baseline	NN	I-NP	O
.	.	.	O	O

Ischemia	Ischemia	NNP	B-NP	O
--	--	:	O	O
pt	pt	JJ	B-NP	O
w/o	w/o	NN	I-NP	O
h/o	h/o	NN	I-NP	O
MI/high	MI/high	NN	I-NP	O
cholesterol/DM	cholesterol/DM	NN	I-NP	O
.	.	.	O	O

+	+	SYM	O	O
smoking	smoking	NN	B-NP	O
w/15	w/15	NN	I-NP	O
packyr	packyr	NN	I-NP	O
smoking	smoking	NN	I-NP	O
.	.	.	O	O

Lipid	Lipid	NN	B-NP	O
panel	panel	NN	I-NP	O
sent	sent	NN	I-NP	O
and	and	CC	O	O
pending	pende	VBG	B-VP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Dobutamine	Dobutamine	NNP	B-NP	O
MIBI	MIBI	NNP	I-NP	O
completed	complete	VBD	B-VP	O
showing	show	VBG	I-VP	O
moderate	moderate	JJ	B-NP	O
size	size	NN	I-NP	O
anterior	anterior	JJ	I-NP	O
septal	septal	JJ	I-NP	O
wall	wall	NN	I-NP	O
defect	defect	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
diagonal	diagonal	JJ	I-NP	O
lesion	lesion	NN	I-NP	O
.	.	.	O	O

Due	Due	JJ	B-PP	O
to	to	TO	I-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
size	size	NN	I-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
technically	technically	RB	I-NP	O
very	very	RB	I-NP	O
limited	limited	JJ	I-NP	O
study	study	NN	I-NP	O
and	and	CC	O	O
these	these	DT	B-NP	O
results	result	NNS	I-NP	O
could	could	MD	B-VP	O
only	only	RB	I-VP	O
be	be	VB	I-VP	O
stated	state	VBN	I-VP	O
with	with	IN	B-PP	O
medium	medium	NN	B-NP	O
probability	probability	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
start	start	VB	I-VP	O
ASA	ASA	NN	B-NP	O
B/C	B/C	NN	I-NP	O
of	of	IN	B-PP	O
vWD	vWD	NN	B-NP	O
but	but	CC	O	O
is	be	VBZ	B-VP	O
already	already	RB	I-VP	O
medically	medically	RB	I-VP	O
managed	manage	VBN	I-VP	O
with	with	IN	B-PP	O
atenolol	atenolol	NN	B-NP	O
and	and	CC	I-NP	O
lisinopril	lisinopril	NN	I-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
need	need	VB	I-VP	O
outpatient	outpatient	NN	B-NP	O
follow	follow	VB	B-VP	O
up	up	IN	B-PRT	O
.	.	.	O	O

HTN	HTN	NN	B-NP	B-protein
--	--	:	O	O
controlled	control	VBN	B-VP	O
on	on	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
ATenolol	ATenolol	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
QD	QD	NNP	I-NP	O
,	,	,	I-NP	O
Lisinopril	Lisinopril	NNP	I-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
QD	QD	NNP	I-NP	O
,	,	,	O	O
Amlodipine	Amlodipine	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
QD	QD	NN	I-NP	O
with	with	IN	B-PP	O
SBP	SBP	NN	B-NP	O
120-150	120-150	CD	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
-	-	HYPH	I-NP	O
vWD	vWD	NN	I-NP	O
.	.	.	O	O

h/o	h/o	NN	B-NP	O
iron	iron	NN	I-NP	O
deficiency	deficiency	NN	I-NP	O
.	.	.	O	O

Not	Not	RB	B-ADJP	O
anemic	anemic	JJ	I-ADJP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
--	--	:	O	O
Patient	Patient	NN	B-NP	O
respiratory	respiratory	JJ	I-NP	O
status	status	NN	I-NP	O
improved	improve	VBN	B-VP	O
with	with	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
with	with	IN	B-PP	O
admission	admission	NN	B-NP	O
8L	8L	NN	I-NP	O
O2	O2	NN	I-NP	O
requirement	requirement	NN	I-NP	O
weaned	wean	VBD	B-VP	O
to	to	TO	B-PP	O
3-4L	3-4L	NN	B-NP	O
with	with	IN	B-PP	O
O2	O2	NN	B-NP	O
91-92	91-92	CD	I-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
her	her	PRP$	B-NP	O
baseline4	baseline4	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

I/D	I/D	NN	B-NP	O
--	--	:	O	O
afebrile	afebrile	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
stay	stay	NN	B-NP	O
;	;	:	O	O
U/A	U/A	NN	B-NP	O
negative	negative	JJ	I-NP	O
;	;	:	O	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
pul	pul	NN	B-NP	B-protein
monary	monary	JJ	I-NP	I-protein
infection	infection	NN	I-NP	I-protein
5	5	CD	I-NP	I-protein
.	.	.	O	O

Endocrine	Endocrine	JJ	B-NP	O
-	-	HYPH	I-NP	O
TSH	TSH	NN	I-NP	O
checked	check	VBN	B-VP	O
as	as	IN	B-PP	O
possible	possible	JJ	B-NP	O
CHF	CHF	NN	I-NP	O
stimulus	stimulus	NN	I-NP	O
;	;	:	O	O
pending	pende	VBG	B-VP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Psych	Psych	NN	B-NP	O
consult	consult	NN	I-NP	O
attained	attain	VBN	B-VP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
with	with	IN	B-PP	O
traumatic	traumatic	JJ	B-NP	O
youth	youth	NN	I-NP	O
and	and	CC	I-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
dependant	dependant	JJ	B-NP	O
personality	personality	NN	I-NP	O
.	.	.	O	O

Thought	Think	VBN	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
insight	insight	NN	B-NP	O
into	into	IN	B-PP	O
medical	medical	JJ	B-NP	O
condition	condition	NN	I-NP	O
but	but	CC	O	O
lack	lack	NN	B-NP	O
of	of	IN	B-PP	O
faith	faith	NN	B-NP	O
in	in	IN	B-PP	O
medications	medication	NNS	B-NP	O
.	.	.	O	O

Poor	Poor	NN	B-NP	O
compliance	compliance	NN	I-NP	O
is	be	VBZ	B-VP	O
by	by	IN	B-PP	O
choice	choice	NN	B-NP	O
.	.	.	O	O

May	May	MD	O	O
benefit	benefit	NN	B-NP	O
from	from	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
social	social	JJ	I-NP	O
work/psychology	work/psychology	NN	I-NP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
as	as	IN	B-PP	O
is	be	VBZ	B-VP	O
somewhat	somewhat	RB	B-ADJP	O
resistant	resistant	JJ	I-ADJP	O
to	to	TO	B-PP	O
psychiatry	psychiatry	NN	B-NP	O
.	.	.	O	O

Re	Re	NN	B-NP	O
.	.	.	O	O

belief	belief	NN	B-NP	O
that	that	WDT	B-NP	O
can	can	MD	B-VP	O
not	not	RB	I-VP	O
touch	touch	VB	I-VP	O
metal	metal	NN	B-NP	O
w/o	w/o	NN	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	I-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
delusions	delusion	NNS	B-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
not	not	RB	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
delusio	delusio	NN	B-NP	O
nal	nal	JJ	B-ADJP	O
or	or	CC	I-ADJP	O
psychotic	psychotic	JJ	I-ADJP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
discharged	discharge	VBD	B-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
VNA	VNA	NN	B-NP	B-protein
visits	visit	NNS	I-NP	I-protein
twice	twice	RB	B-ADVP	O
weekly	weekly	RB	I-ADVP	O
and	and	CC	O	O
transportation	transportation	NN	B-NP	O
arrainged	arrainge	VBD	B-VP	O
for	for	IN	B-PP	O
future	future	JJ	B-NP	O
office	office	NN	I-NP	O
visits	visit	NNS	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
take	take	VBP	B-VP	O
oll	oll	NN	B-NP	O
of	of	IN	B-PP	O
your	your	PRP$	B-NP	O
previously	previously	RB	I-NP	O
prescribed	prescribe	VBN	I-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

Only	Only	RB	B-NP	O
your	your	PRP$	I-NP	O
lasix	lasix	NN	I-NP	O
has	have	VBZ	B-VP	O
bee	bee	NN	B-NP	O
changed	change	VBN	B-VP	O
:	:	:	O	O
please	please	VB	B-INTJ	O
take	take	VB	B-NP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
and	and	CC	O	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
call	call	VB	I-VP	O
this	this	DT	B-NP	O
week	week	NN	I-NP	O
for	for	IN	B-PP	O
follow-up	follow-up	JJ	B-NP	O
appointment	appointment	NN	I-NP	O
to	to	TO	B-VP	O
see	see	VB	I-VP	O
your	your	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-DNA
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Mehok	Mehok	NNP	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
3	3	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
For	For	IN	B-PP	O
VNA	VNA	NN	B-NP	B-protein
:	:	:	O	I-protein
Please	Please	NN	B-NP	I-protein
emphasize	emphasize	VBP	B-VP	O
med	me	VBN	I-VP	O
compliance	compliance	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
chronically	chronically	RB	B-NP	O
noncompliant	noncompliant	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
,	,	,	O	O
focus	focus	NN	B-NP	O
on	on	IN	B-PP	O
cardiopulmonary	cardiopulmonary	JJ	B-NP	O
assess	assess	NN	I-NP	O
,	,	,	O	O
volume	volume	NN	B-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
draw	draw	JJ	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
at	at	IN	B-PP	O
first	first	JJ	B-NP	O
visit	visit	NN	I-NP	O
next	next	JJ	B-NP	O
week	week	NN	I-NP	O
and	and	CC	O	O
inform	inform	NN	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Lunetta	Lunetta	NNP	I-NP	O
of	of	IN	B-PP	O
results	result	NNS	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
JAVERS	JAVERS	NNP	B-NP	O
,	,	,	O	O
JUSTIN	JUSTIN	NNP	B-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SX532	SX532	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
9/5/02	9/5/02	CD	I-NP	O
@	@	NN	I-NP	O
01	01	CD	I-NP	O
:	:	:	O	O
07	07	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

